Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone and Varenicline: Weight Gain and Tolerability in Smokers
NCT00502216Phase 2Completed
- Sponsor
- Yale University
- Start
- Jul 2007
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naltrexone, sponsored by Yale University. Started Jul 2007; status: completed.
02
Drugs
naltrexone
Beyond the preview
Go deeper on NCT00502216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00502216.